PEMOLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pemoline, and when can generic versions of Pemoline launch?
Pemoline is a drug marketed by Actavis Elizabeth, Teva Pharms, Fosun Pharma, Mallinckrodt, Vintage Pharms, and Watson Labs. and is included in eight NDAs.
The generic ingredient in PEMOLINE is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
Summary for PEMOLINE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 5 |
Patent Applications: | 3,595 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PEMOLINE at DailyMed |
Recent Clinical Trials for PEMOLINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical University of Vienna | Phase 2 |
California Pacific Medical Center Research Institute | Phase 2 |
Sheba Medical Center | N/A |